Dealbreaker on MSN
Gilead Sciences Is Acquiring Arcellx and Partnered Multiple Myeloma Drug in $7.8B Deal
Gilead Sciences and Arcellx have been collaborating on the multiple myeloma cell therapy anito-cel since 2022.
The ProScore platform will serve as the system of record for Qcells project teams, select development partners, and third-party auditors, supporting compliance with requirements under the Inflation ...
Astellas Pharma Inc. and Vir Biotechnology, Inc. have entered into a global strategic collaboration to advance VIR-5500, an ...
Vir Biotechnology (NASDAQ:VIR) used its latest investor call to outline a new strategic collaboration with Astellas to advance VIR-5500, a PSMA-directed, dual-masked T-cell engager for prostate cancer ...
It seems like you can’t get Republicans and Democrats to agree on much politically. But, there is one issue both sides are looking to fix. “It’s time to get ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results